Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rohto Pharmaceutical Co's inventories, raw materials & components for the quarter that ended in Mar. 2026 was MXN2,530 Mil.
Rohto Pharmaceutical Co's quarterly raw materials
declined
from Sep. 2025 (MXN2,757 Mil) to Dec. 2025 (MXN2,692 Mil) and
declined
from Dec. 2025 (MXN2,692 Mil) to Mar. 2026 (MXN2,530 Mil).
Rohto Pharmaceutical Co's annual raw materials
increased
from Mar. 2024 (MXN1,809 Mil) to Mar. 2025 (MXN2,764 Mil) but then
declined
from Mar. 2025 (MXN2,764 Mil) to Mar. 2026 (MXN2,530 Mil).
Rohto Pharmaceutical Co Inventories, Raw Materials & Components Historical Data
* Premium members only.
The historical data trend for Rohto Pharmaceutical Co's Inventories, Raw Materials & Components can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rohto Pharmaceutical Co Inventories, Raw Materials & Components Chart
What does a Inventories, Raw Materials & Components of MXN2,530 Mil mean?
Rohto Pharmaceutical Co (MEX:4527N) has a Inventories, Raw Materials & Components of MXN2,530 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Rohto Pharmaceutical Co and its competitors.
Is Rohto Pharmaceutical Co's Inventories, Raw Materials & Components too high?
Rohto Pharmaceutical Co's current Inventories, Raw Materials & Components is MXN2,530 Mil. Overall, Rohto Pharmaceutical Co has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Rohto Pharmaceutical Co's Inventories, Raw Materials & Components compare to PG and CL?
Rohto Pharmaceutical Co's Inventories, Raw Materials & Components of MXN2,530 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Consumer Packaged Goods company?
A good Inventories, Raw Materials & Components depends on the Consumer Packaged Goods industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Rohto Pharmaceutical Co and its competitors. Rohto Pharmaceutical Co's current Inventories, Raw Materials & Components is MXN2,530 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rohto Pharmaceutical Co stock overvalued right now?
Rohto Pharmaceutical Co (MEX:4527N) has a current Inventories, Raw Materials & Components of MXN2,530 Mil. The stock's GF Value™ is MXN428.89, compared to a current price of MXN305.75 — trading 28.7% below its estimated fair value. The current Inventories, Raw Materials & Components is MXN2,530 Mil. Rohto Pharmaceutical Co's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Rohto Pharmaceutical Co (MEX:4527N), the current Inventories, Raw Materials & Components is MXN2,530 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rohto Pharmaceutical Co (MEX:4527N) Overvalued in 2026?
Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued.
The current stock price of MXN305.75 is trading 28.7% below its estimated GF Value™ of MXN428.89.
Key valuation signals for MEX:4527N:
Inventories, Raw Materials & Components: MXN2,530 Mil
GF Value™: MXN428.89 vs. price of MXN305.75 (28.7% below fair value)
No single metric tells the full story. See the MEX:4527N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
92GF Score
Get the complete analysis for MEX:4527N
Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4527N has been successfully added to your 
